24Y-29295-53800
3 vaccinations
1 coded response
35 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 604 / IL
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Moderna
-
2021-01-08
Registered in v-safe
-
2021-01-15
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-21
Survey response — day 14, dose 1MedDRA: Injection site erythema, Pruritus — Feeling: GoodFree text: Itching, redness in shot areaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
-
2021-02-04
Dose 2 — Moderna
-
2021-02-04
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Nausea · Be unable to workAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-06
- 2021-03-11
- 2021-03-18
- 2021-05-06
- 2021-08-05
- 2022-02-05
-
2022-02-09
Dose 3 — Moderna
- 2022-02-09
- 2022-02-10
- 2022-02-11
-
2022-02-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2022-02-13
- 2022-02-14
- 2022-02-15
- 2022-02-16
- 2022-02-23
- 2022-03-03
- 2022-03-09
- 2022-03-16
- 2022-03-23
- 2022-05-13
- 2022-08-10
- 2023-02-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2022-02-09 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-15 | priority 2/3 |
Free text
Release 2 — day 14, dose 1
Symptoms: Itching, redness in shot area
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release